Indefinite Delivery Contract 36C26125D0016
Award Date
10/1/24
Last Date to Order
3/31/25
Federal Agency
Veterans Integrated Service Network 21
Awardee
RLS (USA) Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract has a ceiling value of $4,998,603.38 and a performance period through September 17, 2029. The contract is for the provision of critical radiopharmaceuticals used in nuclear medicine diagnostic services at VA medical centers and military treatment facilities, including gallium-67,...
This Indefinite Delivery Contract (IDC) was awarded by the Veterans Integrated Service Network 5 (VISN 5), a component of the U.S. Department of Veterans Affairs (VA), to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract has a ceiling value of $2,162,919.87 and a period of performance extending to March 31, 2030. The contract is for the provision of radiopharmaceuticals, which are critical for nuclear medicine diagnostic services at VA medical centers. RLS (USA)...
This federal Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the delivery of non-positron emission tomography (non-PET) radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. The contract has a performance period from April 1, 2025, to March 31, 2026, with a ceiling value of $425,725.07. RLS (USA) Inc. is an experienced federal...
This single-award Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, to provide radiopharmaceuticals and related supplies to the VA Northern California Health Care System (VANCHCS). The contract has a ceiling value of $2,500,000 and a performance period through March 31, 2030. Under this IDC, RLS (USA) Inc. will deliver radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18,...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network 21 has awarded an Indefinite Delivery Contract (IDC) worth up to $1,200,000 to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, to provide radiopharmaceuticals and related supplies to VA medical centers and military treatment facilities. The initial task order under this IDC is valued at $179,605.38 and covers the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18,...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2), a civilian agency, to the prime contractor RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company. The contract, valued at $538,493.10, is for the delivery of the radiopharmaceutical product NETSPOT GA-68 to support nuclear medicine imaging procedures at VA medical facilities. RLS (USA) Inc. holds several federal IDV contracts with the VA...
This federal contract IDV award is a Blanket Purchase Agreement (BPA) issued by the Defense Health Agency (DHA), a defense agency within the U.S. Department of Defense, to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The BPA has a ceiling value of $350,000.00 and a performance period from February 17, 2022 to February 16, 2027. The primary contracted products are Gallium-68 Dotatate (NETSPOT), a radiopharmaceutical used in nuclear medicine imaging procedures. The BPA...
RLS USA Inc. was awarded an indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 to provide radiopharmaceutical products. The potential value of the contract is $1,162,500. No set-aside designation was applied. Under the contract, RLS USA Inc. received two delivery orders to date for radiopharmaceutical supplies. The first delivery order, valued at $244,564.67, was awarded on August 2, 2022 for a performance...
The federal contract IDV awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, is for the supply of radiopharmaceuticals. The $740,177.94 firm-fixed-price delivery order contract is part of a larger $39.8 million multiple-award Indefinite Delivery Contract (IDC) with the VA's Network Contracting Office 8, as well as additional IDVs with the VA and Defense Health...
The federal contract indefinite delivery vehicle (IDV) described is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The BPA, awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), has a ceiling value of $1,986,545.40 and a period of performance through September 30, 2029. The primary...